Participate in MDMA Studies

We are currently recruiting for the Phase 3 study of MDMA-assisted therapy for PTSD. Here is a list of all MAPS-sponsored trials on clinicaltrials.gov.

Become a Therapy Provider

Applications are open for practitioners and sites interested in providing limited MDMA therapy within a clinical trial setting.

Read our Publications

MAPS PBC publishes research papers detailing the results of our clinical trials.

MAPS PBC in the Media

New PTSD Treatments Emerge as Cases Rise Among Some Groups

Sept. 21, 2020

PTSD and psychoactive drugs: MDMA treatment shows potential, but others lack evidence

Sept. 21, 2020

The case for funding psychedelics to treat mental health

Oct 9, 2020

MDMA-assisted couples therapy investigated in landmark pilot trial

December 08, 2020

Press Releases

MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.

MAPS Public Benefit Corporation

Our Mission
Who We Are
Careers
News
FAQ
Contact Us

3141 Stevens Creek Blvd #40547
San Jose, CA 95117

MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a 501(c)(3) non-profit research and educational organization.